Next Article in Journal
Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
Previous Article in Journal
Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(11), 2705; https://doi.org/10.3390/cancers14112705
Action Date Notes Link
article xml file uploaded 30 May 2022 13:39 CEST Original file -
article xml uploaded. 30 May 2022 13:39 CEST Update https://www.mdpi.com/2072-6694/14/11/2705/xml
article pdf uploaded. 30 May 2022 13:39 CEST Version of Record https://www.mdpi.com/2072-6694/14/11/2705/pdf
article html file updated 30 May 2022 13:40 CEST Original file -
article html file updated 3 August 2022 02:40 CEST Update https://www.mdpi.com/2072-6694/14/11/2705/html
Back to TopTop